rolipram and ketamine
rolipram has been researched along with ketamine in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Mason, RJ; Mikawa, K; Morikawa, O; Nishina, K; Obara, H | 1 |
Chen, JH; Han, CY; Ko, WC; Lai, CY; Yu, MC | 1 |
Chen, JQ; Liang, YQ; Lu, JJ; Mao, LG; Tang, HF; Tang, JF; Wang, XF; Wang, YJ; Zheng, X | 1 |
Other Studies
3 other study(ies) available for rolipram and ketamine
Article | Year |
---|---|
The effects of intravenous anesthetics and lidocaine on proliferation of cultured type II pneumocytes and lung fibroblasts.
Topics: Anesthetics, Dissociative; Anesthetics, Intravenous; Anesthetics, Local; Animals; Cell Division; Cells, Cultured; Dimethyl Sulfoxide; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Fibroblasts; Hepatocyte Growth Factor; Ketamine; Lidocaine; Lung; Male; Midazolam; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Rolipram; Thiopental | 2002 |
Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1-5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia.
Topics: Anesthesia; Animals; Binding, Competitive; Female; Guinea Pigs; Ketamine; Luteolin; Male; Mice; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Binding; Rolipram; Tritium; Xylazine | 2010 |
Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Lung Injury; Anesthetics; Animals; Anti-Inflammatory Agents; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Cyclic Nucleotide Phosphodiesterases, Type 4; Dexamethasone; Furans; Intubation, Intratracheal; Ketamine; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Peroxidase; Phenyl Ethers; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Rolipram; Tumor Necrosis Factor-alpha; Xylazine | 2010 |